KANSAS: New COVID-19 outpatient treatments including pill, injection and inhaled medicine part of clinical trial at KU Medical Center

Three new outpatient treatments will be tested at the University of Kansas Medical Center in efforts to broaden options for COVID-19 patients. These new treatments may make it easier to receive COVID-19 treatment outside a hospital, as they include:

• an oral pill
• an injection
• a medication that can be inhaled through a home nebulizer.

Mario Castro, M.D., MPH, vice chair for clinical and translational research in the Department of Internal Medicine and a pulmonologist at the University of Kansas School of Medicine, said, "Right now, monoclonal antibodies are the only effective outpatient treatment option against COVID," Castro said. "This study design enables us to quickly add new drugs and examine new treatment types while using the same sites and the same staff."

All of the drugs are being tested as part of a unique nationwide clinical trial known as Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV-2), which allows multiple drugs to be tested under the same trial protocol, saving time and effort.

Read the full article here.